TS - My bank is yet to get the ASBA facility and expected soon. I continue with this bank for the proximity. Well, I thought ASBA lien can be done with only savings account and it earns only 4% interest rate. May be I have to check with some bank which has this auto FD facility. Thanks.
DEAR VAS NAT, REGARDING YOUR QUERY HERE IS MY CLARIFICATION,WHEN WE ARE APPLYING TH ASBA,ONLY AMOUNT IS BLOCKED NOT DEBITED THEREFORE THERE IS NO QUESTION OF CHARGING EXTRA INTT.AMOUNT.AND WE CAN EASILY KNOW BY SUBSCRIPTION FIGURES WE CAN EASILY CALCULATE THE AMOUNT FOR ALLOTTED SHARES,WHICH WE CAN DEPOSIT BEFORE ALLOTMENT DAY AND RELEASE OF ASBA BLOCKED AMOUNT,THUS OUR AUTO FD AMOUNT REAMINS SAFE AND WE EARN INT AT HIGHER RATE PLAY SAFE .IN GOOD ISSUES WE ARE ONLY GETTING SHARES WORTH RS 10000 ROUGHLY.I ONLY FOLLOW THE ADVICE OF SREEDHAR AND APPLY ACCORDINGLY.I NEVER RUN FOR FARZI SHARES LIKE RAVI,SUDAR,FINOTEX BECAUSE THEY CAN GO EITHER WAY BECAUSE SAVING HARD EARNED MONEY IS BETTER THAN LOSING .RECENTLY I HAVE APPLIED IN SBI BONDS ONLY AFTER SREEDHAR RECOMMENDATION WHICH WILL GIVE SAFER RETURN IT MAY BE MUCH LESS THAN THAT PEOPLE EARNED IN RAVI,SUDAR ETC.ONE MORE THING I WISH TO SAY THAT IPO WITH GOOD REPUTATION GIVES SAFE RETURN WHICH IS BETTER THAN EARNED IN HIGH RISK HIGH GAIN IPO.I MAY BE WRONG BUT I ALWAYS FOLLOW SREEDHAR WHO HAS LOT OF KNOWLEDGE AND STUDY OF SHARES. THANKS TS
iagnostics services provider Super Religare Laboratories (formerly SRL Ranbaxy) proposes to enter capital market with a public issue of up to 2.8 crore equity shares of face value of Rs 10 each. The issue shall constitute 35% of the fully diluted post-issue paid up capital of the company. Company is going to consider a private placement (pre-IPO placement) of up to 80 lakh equity shares, aggregating up to Rs 160 crore . Super Religare is one of the leading diagnostics services companies in India. The company had acquired Piramal Diagnostic Services Private Limited (PDSPL) in August 2010; with this acquisition - it has the largest market share (48%) in the organized sector in India, (according to ICRA Management Consulting Services Limited, Indian Diagnostics Services Market Report, January 2011. The company intends to utilise the issue proceeds providing loan to the subsidiary, PDSPL for repayment of its existing debt; redemption of non-convertible debentures; redemption of non-cumulative redeemable preference shares issued by company and repayment of debt taken for the purpose of capital expenditure. Promoters of the company are Malvinder Singh, Shivinder Singh, Malav Holdings Pvt Ltd, Shivi Holdings Pvt Ltd, Oscar Investments Limited and Maple Leaf Buildcon Pvt Ltd. Promoters' shareholding will be reduced to 55.69% from 85.67% post issue. Nomura Financial Advisory & Securities (INDIA) Pvt Ltd, Kotak Mahindra Capital Company Limited and Religare Capital Markets Limited are the book running lead managers to the issue.
I am surprised to see my messages are edited / removed when the source of the information is given. I just want to inform boarders that this is not my own and has been taken from somewhere else to have genunity which most members including Sreedhar wishes for.
You might as least edit the source to some XXX or something else because just deleting the sentences mean to say those are my own writings which is not. And finally, I neither advertise nor have any personal interest for those websites/links.